Operose Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.1K | Hold |
2,036
| – | – | 0.01% | 260 |
|
|
2025
Q1 | $31.3K | Hold |
2,036
| – | – | 0.01% | 246 |
|
|
2024
Q4 | $44.9K | Hold |
2,036
| – | – | 0.02% | 218 |
|
|
2024
Q3 | $36.7K | Hold |
2,036
| – | – | 0.01% | 314 |
|
|
2024
Q2 | $33.1K | Hold |
2,036
| – | – | 0.01% | 285 |
|
|
2024
Q1 | $28.7K | Hold |
2,036
| – | – | 0.01% | 326 |
|
|
2023
Q4 | $21.3K | Hold |
2,036
| – | – | 0.01% | 356 |
|
|
2023
Q3 | $20.8K | Hold |
2,036
| – | – | 0.01% | 475 |
|
|
2023
Q2 | $15.3K | Hold |
2,036
| – | – | 0.01% | 254 |
|
|
2023
Q1 | $18K | Hold |
2,036
| – | – | 0.01% | 235 |
|
|
2022
Q4 | $18.6K | Buy |
2,036
+36
| +2% | +$328 | 0.01% | 225 |
|
|
2022
Q3 | $16K | Buy |
+2,000
| New | +$16K | 0.01% | 235 |
|